Volume 8, Number 2—February 2002
Research
Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
Table 4
Number of cystic fibrosis patients infected with Burkholderia cepacia complex genomovar III RAPD strain type, by Canadian province
| Province | RAPD strain type |
||||
|---|---|---|---|---|---|
| 01 | 02 | 04 | 06 | Other (BCESM+)a | |
| British Columbia | 9 | 11 | 16 | 7 | 10 (5) |
| Alberta | 2 | 14 | 16 | 0 | 0 |
| Manitoba | 0 | 1 | 1 | 0 | 1 (0) |
| Saskatchewan | 0 | 0 | 0 | 0 | 0 |
| Ontario | 1 | 223 | 2 | 0 | 7 (5) |
| Quebec | 5 | 7 | 1 | 0 | 2 (2) |
| Prince Edward Island | 0 | 0 | 0 | 0 | 0 |
| New Brunswick | 0 | 0 | 2 | 0 | 1 (0) |
| Nova Scotia | 0 | 2 | 12 | 0 | 4 (0) |
| Newfoundland |
0 |
13 |
0 |
0 |
0 |
| Total | 17 | 271 | 50 | 7 | 25 (12) |
aNumber of patients whose isolates had Burkholderia cepacia epidemic strain marker (BCESM ) in the category “other genomovar III RAPD strain types”. Strain types 01, 02, 04, and 06 all encoded BCESM. RAPD = random amplified polymorphic DNA.
